Back to top
more

QuidelOrtho (QDEL)

(Delayed Data from NSDQ)

$24.40 USD

24.40
1,724,666

+0.96 (4.10%)

Updated Aug 7, 2025 04:00 PM ET

After-Market: $24.42 +0.02 (0.08%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (156 out of 246)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Has Quidel (QDEL) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Is (QDEL) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

Why the Earnings Surprise Streak Could Continue for Quidel (QDEL)

by Zacks Equity Research

Quidel (QDEL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

Top Ranked Momentum Stocks to Buy for October 6th

by Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 6th

Kevin Cook headshot

7 Diagnostic and Genomic Stocks Storming Into October

by Kevin Cook

COVID-19 has created an Apollo Mission status for advanced medical technologies and smart investors are profiting.

Zacks Equity Research

AngioDynamics (ANGO) Q1 Earnings and Revenues Top Estimates

by Zacks Equity Research

AngioDynamics (ANGO) witnessed revenue growth across two business segments in fiscal Q1.

Zacks Equity Research

Quidel (QDEL) Stock Moves -1.39%: What You Should Know

by Zacks Equity Research

Quidel (QDEL) closed at $196.21 in the latest trading session, marking a -1.39% move from the prior day.

Zacks Equity Research

NEOGEN (NEOG) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

NEOGEN's (NEOG) segmental revenues improve for the fiscal first quarter on strong sales of cleaners, disinfectants and sanitizers.

Zacks Equity Research

Rockwell Medical (RMTI) Soars: Stock Adds 9.7% in Session

by Zacks Equity Research

Rockwell Medical (RMTI) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.

Zacks Equity Research

Is Quidel (QDEL) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Is (QDEL) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

Quidel (QDEL) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Quidel (QDEL) closed the most recent trading day at $159.39, moving -1.12% from the previous trading session.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Quest Diagnostics, Abbott, Quidel, QIAGEN and Thermo Fisher Scientific

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Quest Diagnostics, Abbott, Quidel, QIAGEN and Thermo Fisher Scientific

Zacks Equity Research

Quidel Enters Oversold Territory

by Zacks Equity Research

Quidel has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

Urmimala Biswas headshot

Coronavirus Test Makers With Scope to Maximize Investor Benefits

by Urmimala Biswas

The surge in new coronavirus infections broadens the scope for antigen and antibody tests.

Zacks Equity Research

Omeros (OMER) Catches Eye: Stock Jumps 6%

by Zacks Equity Research

Omeros (OMER) saw a big move last session, as its shares jumped 6% on the day, amid huge volumes.

Panel Of Zacks Experts headshot

Top Stock Picks for Week of September 8, 2020

by Panel Of Zacks Experts

Take a look at our expert's weekly picks which include Quidel (QDEL) and American Woodwork (AMWD).

Zacks Equity Research

Is Quidel (QDEL) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Is (QDEL) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

Surface Oncology (SURF) Looks Good: Stock Adds 9.8% in Session

by Zacks Equity Research

Surface Oncology (SURF) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Abbott Lab, Quidel, Becton, Dickinson and Company, Hologic and Quest Diagnostics

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Abbott Lab, Quidel, Becton, Dickinson and Company, Hologic and Quest Diagnostics

Urmimala Biswas headshot

Price War in Coronavirus Test Space to Intensify Thanks to Abbott

by Urmimala Biswas

Most rapid antigen tests in the United States require an additional system, which is making the procedures more costly and complex.

Nalak Das headshot

7 Top-Ranked Corporate Giants With More Than 50% Return YTD

by Nalak Das

A handful of corporate giants (market capital > $10 billion) have skyrocketed this year, braving the pandemic and its impact on businesses.

Zacks Equity Research

Has Quidel (QDEL) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Is (QDEL) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

Should iShares Morningstar SmallCap Growth ETF (JKK) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for JKK

Kevin Cook headshot

Bull of the Day: Quidel (QDEL)

by Kevin Cook

Multiple FDA approvals for new 15-minute COVID-19 antigen tests have estimates and shares rising sharply

Zacks Equity Research

Quidel's Shares March Higher, Can It Continue?

by Zacks Equity Research

As of late, it has definitely been a great time to be an investor in Quidel.

Zacks Equity Research

ICU Medical (ICUI) Looks Good: Stock Adds 8.1% in Session

by Zacks Equity Research

ICU Medical (ICUI) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.